ghk-cu peptide boston Asterwood Copper Peptides Serum for Face, w/Hyaluronic Acid mg:20mg X 3pk IGF-1 Research bpc-157 clinical studies Trials

ghk-cu peptide boston Asterwood Copper Peptides Serum for Face, w/Hyaluronic Acid mg:20mg X 3pk IGF-1 Research bpc-157 clinical studies Trials

bpc-157 clinical studies Trials Planned by Johns Hopkins Physician | Christopher L. Robinson, MD PhD posted on the topic The Stable Gastric Pentadecapeptide BPC –

Scharf, M

IGF-1 Research

mg:20mg X 3pk

2017 Cell study used 5 mg/kg intraperitoneal injection three times per week in aged mice, with treatment periods of several weeks — the three-times-weekly dosing suggests the peptide maintains sufficient functional concentrations for at least 48-72 hours per dose (PMID: 28340339)